Advanced company searchLink opens in new window

COVID BIOPHARMA LIMITED

Company number 12570359

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Sep 2024 AA Accounts for a dormant company made up to 31 December 2023
02 May 2024 CS01 Confirmation statement made on 22 April 2024 with updates
29 Sep 2023 AA Accounts for a dormant company made up to 31 December 2022
24 Apr 2023 PSC04 Change of details for Mr Peter Kadas as a person with significant control on 24 April 2023
24 Apr 2023 CH01 Director's details changed for Mr Gabor Istvan Illes on 24 April 2023
24 Apr 2023 CH01 Director's details changed for Mr Daniel Arthur Hallgarten on 24 April 2023
24 Apr 2023 AD01 Registered office address changed from 85 Great Portland Street, First Floor London W1W 7LT United Kingdom to 1st Floor 40-44 Newman Street London W1T 1QD on 24 April 2023
22 Apr 2023 PSC04 Change of details for Mr Peter Kadas as a person with significant control on 22 April 2023
22 Apr 2023 CS01 Confirmation statement made on 22 April 2023 with updates
19 Oct 2022 CH01 Director's details changed for Mr Daniel Arthur Hallgarten on 18 October 2022
20 Sep 2022 AA Accounts for a dormant company made up to 31 December 2021
05 May 2022 CS01 Confirmation statement made on 22 April 2022 with updates
14 Sep 2021 AA Accounts for a dormant company made up to 31 December 2020
29 Apr 2021 CS01 Confirmation statement made on 22 April 2021 with updates
16 Dec 2020 AA01 Current accounting period shortened from 30 April 2021 to 31 December 2020
16 Dec 2020 TM01 Termination of appointment of Eniko Toke as a director on 15 December 2020
16 Dec 2020 TM01 Termination of appointment of Peter Kadas as a director on 15 December 2020
16 Dec 2020 TM01 Termination of appointment of Christopher Gallen as a director on 15 December 2020
23 Apr 2020 NEWINC Incorporation
Statement of capital on 2020-04-23
  • USD 100